Masahiko Moriguchi

Age-Stratified Effect of Rivaroxaban Monotherapy for Atrial Fibrillation in Stable Coronary Artery Disease

Junichi Yamaguchi, Hiroyuki Arashi, Nobuhisa Hagiwara, Satoshi Yasuda et autres

Importance: Antithrombotic therapy is crucial for older patients with coronary artery disease (CAD) and atrial fibrillation (AF) who are at a high risk of bleeding and thrombotic events. Objective: To examine the age-stratified effects of rivaroxaban monotherapy compared with those of rivaroxaban …

jp (code pays fourni par la source)

Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease

Ryo Naito, Katsumi Miyauchi, Satoshi Yasuda, Koichi Kaikita et autres

Importance: Appropriate regimens of antithrombotic therapy for patients with atrial fibrillation (AF) and coronary artery disease (CAD) have not yet been established. Objective: To compare the total number of thrombotic and/or bleeding events between rivaroxaban monotherapy and combined rivaroxaban and antiplatelet therapy …

jp (code pays fourni par la source)

Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting

Tetsuya Matoba, Satoshi Yasuda, Koichi Kaikita, Masaharu Akao et autres

jp (code pays fourni par la source)

Therapeutic strategy using extracorporeal life support, including appropriate indication, management, limitation and timing of switch to ventricular assist device in patients with acute myocardial infarction

Naoyoshi Aoyama, Hiroshi Imai, Toshiro Kurosawa, Naoto Fukuda et autres

jp, kr (code pays fourni par la source)

Therapeutic strategy for extracorporeal life support in patients with acute myocardial infarction complicating cardiopulmonary arrest

Naoyoshi Aoyama, Toshiro Kurosawa, Nobuhiko Fukuda, Masahiko Moriguchi et autres

Purpose and methods: The therapeutic strategy for extracorporeal life support (ECLS), including the appropriate indication, management, limitation, and timing to switch from ECLS to a ventricular assist device (VAD), has not been fully characterized and remains a controversial issue in patients with …

jp (code pays fourni par la source)

Combined effects of up- and downstream therapies on atrial fibrillation in a canine rapid stimulation model

Hidehira Fukaya, Shinichi Niwano, Hiroe Niwano, Yoshihiko Masaki et autres

jp (code pays fourni par la source)

Importance of Morphological Changes in T-U Waves During Bepridil Therapy as a Predictor of Ventricular Arrhythmic Event

Sayaka Kurokawa, Shinichi Niwano, Michiro Kiryu, Masami Murakami et autres

BACKGROUND: Although bepridil is a useful anti-arrhythmic agent for atrial fibrillation, the appearance of serious ventricular arrhythmia, such as torsades de pointes, might be a problem. In this study, T-U wave morphology was evaluated during bepridil therapy and was examined as a …

jp (code pays fourni par la source)

Hemodialysis is an Independent Predictor of Coronary In-stent Restenosis after Paclitaxel Eluting Stent Implantation

Ichiro Takeuchi, Masahiko Moriguchi, Ryuta Imaki, Hidehira Fukaya et autres

OBJECTIVE: A drug eluting stent is often used for high-risk patients with complications such as diabetes mellitus (DM) and hemodialysis (HD), however the factors to predict restenosis after paclitaxel-eluting stent (PES) placement have not been reported to date. METHODS: Between May 2007 …

jp (code pays fourni par la source)

Attenuating Effects of Anti‐Arrhythmic Agents on Changes in Fibrillation Cycle Length in Very Early Phase Paroxysmal Atrial Fibrillation —Spectral Analysis of Fibrillation Waves in Surface ECG—

Hidehira Fukaya, Shinichi Niwano, Takeshi Sasaki, Michiro Kiryu et autres

Background: Antiarrhythmic agents may affect electrical remodeling but little is known regarding clinical cases. We evaluated fibrillation cycle length (FCL) of atrial fibrillation (AF) by spectral analysis of fibrillation waves (FW) in surface ECG for patients on antiarrhythmic agents. Methods and Results: …

jp (code pays fourni par la source)

The Long Term Effect of Amiodarone Therapy for Prevention of Arrhythmic Events in Patients With Implantable Cardioverter-Defibrillator (ICD)

Michiro Kiryu, Shinichi Niwano, Sayaka Kurokawa, Hidehira Fukaya et autres

jp (code pays fourni par la source)

PJ-689 Left Ventricular Remodeling is Predictable by the Number of Premature Ventricular Contraction (PVC) in Patients with Idiopathic Frequent PVCs(PJ116,Ventricular Arrhythmia (Clinical/Pathophysiology) (A),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)

Shinichi Niwano, Michiro Kiryu, Sayaka Kurokawa, Hidehira Fukaya et autres

Attenuating Effects of Anti-Arrhythmic Agents on Changes in Fibrillation Cycle Length in Very Early Phase Paroxysmal Atrial Fibrillation-Spectral Analysis of Fibrillation Waves in Surface ECG-

Hidehira Fukaya, Shinichi Niwano, Takeshi Sasaki, Michiro Kiryu et autres